AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO - Seite 2

Adi Shemer, the Company's new CEO, stated, "I am excited to join and lead AppYea, as the company transitions to the commercial phase of its growth. The Company's patented and AI-based sensing technologies for the tracking and analysis of breathing patterns, are truly transformative in their ability to provide greater accuracy at lower cost. The snoring and sleep apnea devices addresses a significant and underserved market, which could revolutionize how we diagnose and treat these conditions.​ Moreover, the combined markets for these devices have shown consistent double-digit growth and amount to more than a $10 billion addressable market. Looking ahead, our strategy is laser focused on advancing regulatory approval of SleepX Pro and DreamIT Pro, as well as commercialization of SleepX through direct-to-consumer marketing, as well as establishing relationships with third-party sales organizations, distributors, pharmacies, chain stores, online stores, and others. I look forward to leveraging both my experience and deep industry relationships to drive value for shareholders."

Boris (Bary) Molchadsky, AppYea's Chairman, further noted, "I am honored to welcome Adi as CEO of the Company. He brings an impressive track record commercializing and expanding international sales of medical devices. Since joining our advisory board, he has added tremendous value to the organization, and I am quite confident in his abilities as our new CEO to help us realize the full potential of AppYea as we move into the commercial phase."

About SleepX

SleepX is an Israeli research and development company, recently acquired by AppYea. The company had developed a unique product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents and the company plans to start serial production of its flagship product DreamIT in the coming weeks.

About AppYea

AppYea is a healthtech company commercializing a breakthrough wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost.